INTRODUCTION
Jr a is a high-frequency antigen that has been included in the 901 series (antigen number, 901005) of the International Society of Blood Transfusion blood group classification [1] . The frequency of occurrence of this antigen is known to be over 99% in most ethnic groups [2] . Although the Japanese population is known to have the highest number of Jr(a-) individuals, the incidence of the Jr(a-)
phenotype is estimated to be only 0.03-0.12% even in the Japanese population [3] , and this percentage is thought to be lower in Caucasians, Mexicans, and Arabs [4] . The incidence of the Jr(a-) phenotype in the Korean population has not yet been reported. 
Jr
a is a high-frequency antigen found in all ethnic groups. However, the clinical significance of the anti-Jr a antibody has remained controversial. Most studies have reported mild hemolytic disease of the newborn and fetus (HDNF) in Jr a -positive patients. Recently, fatal cases of HDNF have also been reported. We report the first case of HDNF caused by anti-Jr a alloimmunization in twins in Korea. A 33-yr-old nulliparous woman with no history of transfusion or amniocentesis was admitted at the 32nd week of gestation because of vaginal bleeding caused by placenta previa. Anti-Jr a antibodies were detected in a routine laboratory examination. An emergency cesarean section was performed at the 34th week of gestation, and 2 premature infant twins were delivered. Laboratory examination showed positive direct antiglobulin test and Jr(a+) phenotype in the red blood cells and the presence of anti-Jr a antibodies in the serum in both neonates. The infants underwent phototherapy for neonatal jaundice; this was followed by conservative management. They showed no further complications and were discharged on the 19th postpartum day. Preparative management to ensure the availability of Jr(a-) blood, via autologous donation, and close fetal monitoring must be performed even in cases of first pregnancy in Jr(a-) women. 
CASE REPORT
A 33-yr-old nulliparous woman in her 32nd gestational week visited the emergency room because of vaginal bleeding. Her medical history was unremarkable except for the fact that she was a hepatitis B carrier. and that they can cross the placenta [3, 9] . The Jr a antigen has also been reported to be fully developed at birth [7] . Although anti-Jr a antibodies can be stimulated by a first pregnancy, HDNF associated with anti-Jr a antibody was thought to occur in subsequent pregnancies [6] . However, in our case, the mother was nulliparous and had One of the difficulties in identifying anti-Jr a antibodies is the lack of commercially available antisera. A human monoclonal anti-Jr a antibody has been produced from a human-mouse heterohybridoma (HMR0921) [20] . However, the biochemical structure of the Jr a antigen and the molecular basis of the Jr(a-) phenotype are currently unknown [6] . Our laboratory has been identifying anti- Nevertheless, close monitoring of the patient is necessary while performing subsequent transfusions.
